PMD17 Clinical and Economic Outcomes Derived from the Use of a Chlorhexidine – Impregnated Sponge (Biopatch®) for the Prevention of Cather-Related Bloodstream Infections in Intensive Care Units in Mexico
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.357
https://www.valueinhealthjournal.com/article/S1098-3015(12)00422-6/fulltext
Title :
PMD17 Clinical and Economic Outcomes Derived from the Use of a Chlorhexidine – Impregnated Sponge (Biopatch®) for the Prevention of Cather-Related Bloodstream Infections in Intensive Care Units in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00422-6&doi=10.1016/j.jval.2012.03.357
First page :
A65
Section Title :
Medical Device/Diagnostics
Open access? :
No
Section Order :
1144